Costello Jennifer L, Torowicz Deborah Lloyd, Yeh Timothy S
Children's Hospital of New Jersey at Newark Beth Israel Medical Center, Newark 07112, USA.
Am J Health Syst Pharm. 2007 Jul 1;64(13):1422-6. doi: 10.2146/ajhp060296.
The effects of a pharmacist-led pediatrics medication safety team (PMST) on the frequency and severity of medication errors reported were studied.
This study was conducted in a pediatric critical care center (PCCC) in three phases. Phase 1 consisted of retrospective collection of medication-error reports before any interventions were made. Phases 2 and 3 included prospective collection of medication-error reports after several interventions. Phase 2 introduced a pediatrics clinical pharmacist to the PCCC. A pediatrics clinical pharmacist-led PMST (including a pediatrics critical care nurse and pediatrics intensivist), a new reporting form, and educational forums were added during phase 3 of the study. In addition, education focus groups were held for all intensive care unit staff. Outcomes for all phases were measured by the number of medication-error reports processed, the number of incidents, error severity, and the specialty of the reporter.
Medication-error reporting increased twofold, threefold, and sixfold between phases 1 and 2, phases 2 and 3, and phases 1 and 3, respectively. Error severity decreased over the three time periods. In phases 1, 2, and 3, 46%, 8%, and 0% of the errors were classified as category D or E, respectively. Conversely, the reporting of near-miss errors increased from 9% in phase 1 to 38% in phase 2 and to 51% in phase 3.
An increase in the number of medication errors reported and a decrease in the severity of errors reported were observed in a PCCC after implementation of a PMST, provision of education to health care providers, and addition of a clinical pharmacist.
研究由药剂师主导的儿科用药安全团队(PMST)对所报告用药错误的频率和严重程度的影响。
本研究在一家儿科重症监护中心(PCCC)分三个阶段进行。第一阶段包括在未进行任何干预之前回顾性收集用药错误报告。第二阶段和第三阶段包括在进行若干干预之后前瞻性收集用药错误报告。第二阶段向PCCC引入了一名儿科临床药剂师。在研究的第三阶段增加了一个由儿科临床药剂师主导的PMST(包括一名儿科重症监护护士和一名儿科重症专家)、一种新的报告表格以及教育论坛。此外,还为所有重症监护病房的工作人员举办了教育焦点小组会议。所有阶段的结果通过处理的用药错误报告数量、事件数量、错误严重程度以及报告者的专业进行衡量。
在第一阶段和第二阶段之间、第二阶段和第三阶段之间以及第一阶段和第三阶段之间,用药错误报告分别增加了两倍(增至三倍)、三倍(增至六倍)和六倍。在这三个时间段内,错误严重程度有所下降。在第一阶段、第二阶段和第三阶段,分别有46%、8%和0%的错误被归类为D类或E类。相反,险些发生的错误报告从第一阶段的9%增加到第二阶段的38%,并增加到第三阶段的51%。结论:在PCCC实施PMST、为医疗保健提供者提供教育并增加一名临床药剂师之后,观察到所报告的用药错误数量增加,而所报告错误的严重程度降低。